Similar Items: Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
- Successful Treatment of Anti-Jo-1 Positive Inflammatory Myopathy With Tofacitinib
- Subcutaneous Emphysema and Severe Interstitial Lung Disease in the Setting of Anti-MDA 5 Positive Dermatomyositis in a Hispanic Patient
- Type I interferon overactivation in sera of patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease
- Demographic and clinical characteristics of children with juvenile dermatomyositis in Cape Town
- EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis